All Online

1 - 8 of 8 results

Refine

Active filters

Menopause and Hormone Therapy
1 CME CREDIT

Information reaches clinicians at a fast and furious pace. This session will help you keep up with a review of some recent literature that impacts the health of women and other individuals. During this session, the faculty will discuss recent findings on the following topics: hormonal therapy and cancer risk, the role of testosterone in women’s health, HPV immunizations and rates of cervical cancer, and prevention strategies for breast cancer, including chemo prophylaxis for high risk individuals, guidelines for BRCA screening, and comparison of various mammography recommendations. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on February 7, 2020 and they are subject to change as new information is published.


1 CME CREDIT

Information reaches clinicians at a fast and furious pace. This session will help you keep up with a review of some recent literature that impacts the health of women and other individuals. During this session, the faculty will discuss recent findings on the following topics: hormonal therapy and cancer risk, the role of testosterone in women’s health, HPV immunizations and rates of cervical cancer, and prevention strategies for breast cancer, including chemo prophylaxis for high risk individuals, guidelines for BRCA screening, and comparison of various mammography recommendations.


1 CME CREDIT

Initial findings of the Women’s Health Initiative (WHI) published in 2002 forever changed the way menopause hormone therapy has been viewed in the United States. After WHI, use of systemic menopause hormone therapy (MHT) decreased by as much as 80 percent among U.S. women. In the following decade and half, additional data derived from WHI coupled with new research findings resulted in confusion and misunderstandings for patients and clinicians alike on the appropriate use of MHT to manage menopause. This presentation will blend the findings of WHI with newer learnings and provide a practical approach to using MHT.


1 CME CREDIT

Top Questions I Get Asked…Contraception and Menopause

1.00 CME/MOC
1.00 AANP | 1.00 Pharmacology

What do primary care providers need to know about contraception and menopause? Join expert faculty as they review important questions they get asked about these topics!


0.75 CME CREDIT

Participate in this activity to get the most up-to-date information about menopause, systemic hormone therapy, and alternative treatment options to individualize and optimize care of your patients.


1 CME CREDIT

Although women make up a majority of the population and typically the majority of primary care providers patient panel, it is well established that many gender specific needs of women, such as menopause and sexual health, are neglected, in part due to lack of women’s health education in these areas. In today’s panel, 3 women’s health experts will discuss 3 women’s health cases that highlight current data and best practice for management of early menopause, GSM, and women known to carry a genetic mutation that elevates their risk of breast and ovarian cancer.


1 CME CREDIT

Addressing the Needs of Patients with Vasomotor Symptoms of Menopause: Current and Future Approaches

An Interactive Video Experience This course is hosted by an external partner. By clicking Launch Course, you will be directed off of Pri-Med.com. Upon completing the activity, you will be prompted to return to Pri-Med.com

1.00 CME/MOC
1.00 AANP | 0.75 Pharmacology

Hot flashes and night sweats affect most women during the menopause transition and last for 7 to 10 years, on average. Despite the availability of both hormonal and nonhormonal therapies, most women receive no treatment at all. In this activity, expert faculty will review novel nonhormonal treatments in development as well as a range of available treatment options.


Woman sitting on porch, holding her head with one hand
1 CME CREDIT

Menopause Hormone Therapy: Where We Are Now

1.00 CME/MOC
1.00 AANP | 0.67 Pharmacology

Initial findings of the Women’s Health Initiative (WHI) published in 2002 forever changed the way menopause hormone therapy has been viewed in the United States. After WHI, use of systemic menopause hormone therapy (MHT) decreased by as much as 80 percent among U.S. women. In the following decade and half, additional data derived from WHI coupled with new research findings resulted in confusion and misunderstandings for patients and clinicians alike on the appropriate use of MHT to manage menopause. This presentation will blend the findings of WHI with newer learnings and provide a practical approach to using MHT.